NCT00310687View on ClinicalTrials.gov

Persistence of Immune Response After Vaccination With MCC

PHASE4CompletedINTERVENTIONAL

Enrollment

1,244

Participants

Timeline

Start Date

October 31, 2004

Primary Completion Date

December 31, 2005

Study Completion Date

December 31, 2005

Conditions

Prevention of Meningococcal Infection

Interventions

PROCEDURE

BLOOD DRAW

Trial Locations (1)

OX3 9DU

Centre for Clinical Vaccinology and Tropical Medicine, Churchill Hospital, Headington

Sponsors

Lead Sponsor

Collaborators (1)

Novartis Vaccines

All Listed Sponsors

collaborator

Novartis Vaccines

INDUSTRY

lead

Novartis

INDUSTRY